Single-agent vinorelbine as third-line chemotherapy for refractory non-small cell lung cancer.

MLA

Kanat, Özkan, et al. “Single-Agent Vinorelbine as Third-Line Chemotherapy for Refractory Non-Small Cell Lung Cancer.” Turkish Journal of Cancer, vol. 36, no. 3, July 2006, pp. 133–37. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=asx&AN=25068885&authtype=sso&custid=ns315887.

APA

Kanat, Ö., Ölmez, F., Kurt, E., Yildiz, A., Evrensel, T., Kanat, E., & Manavoğlu, O. (2006). Single-agent vinorelbine as third-line chemotherapy for refractory non-small cell lung cancer. Turkish Journal of Cancer, 36(3), 133–137.

Chicago

Kanat, Özkan, Fatıh Ölmez, Ender Kurt, Abdülmecıt Yildiz, Türkkan Evrensel, Elvan Kanat, and Osman Manavoğlu. 2006. “Single-Agent Vinorelbine as Third-Line Chemotherapy for Refractory Non-Small Cell Lung Cancer.” Turkish Journal of Cancer 36 (3): 133–37. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=asx&AN=25068885&authtype=sso&custid=ns315887.